Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Toripalimab Renal Cell Carcinoma	Jinling Hospital, China	P3	BB (67)
TRASTUZUMAB Neoplasm Metastasis	Genentech, Inc.	P3	BB (67)
Blinatumomab B-Cell Adult Acute Lymphocytic Leukemia	Memorial Sloan Kettering Cancer Center	P2	BB (67)
Blinatumomab Philadelphia Chromosome Positive	M.D. Anderson Cancer Center	P2	BB (67)
Durvalumab Recurrent Ovarian Carcinoma	AGO Research GmbH	P2	BB (67)
Durvalumab Recurrent Primary Peritoneal Carcinoma	National Cancer Institute (NCI)	P2	BB (67)
Favezelimab Hodgkins Lymphoma	Merck Sharp & Dohme LLC	P2	BB (67)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Anatomic Stage IV Breast Cancer AJCC v8	Puma Biotechnology, Inc.	P2	BB (67)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Epstein-Barr Virus Infection	Jennifer Amengual	P2	BB (67)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Breast Carcinoma	National Cancer Institute (NCI)	P2	BB (67)
Obinutuzumab B-Cell Non-Hodgkin Lymphoma	Brown University	P2	BB (67)
Pembrolizumab Ovarian Serous Adenocarcinoma	Roswell Park Cancer Institute	P2	BB (67)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Osteopetrosis	Masonic Cancer Center, University of Minnesota	P2/3	BB (67)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Severe Combined Immunodeficiency	Washington University School of Medicine	P2/3	BB (67)
Pembrolizumab Metastatic Malignant Neoplasm	InSilico Medicine Hong Kong Limited	P2/3	BB (67)
Pembrolizumab Metastatic Pancreatic Cancer	Essen Biotech	P2/3	BB (67)
Serplulimab Non-Small Cell Lung Carcinoma	Tang-Du Hospital	P2/3	BB (67)
Cetuximab Colorectal Neoplasm	Zhejiang University	P4	BB (66)
Cetuximab Malignant Pancreatic Neoplasm	Chinese PLA General Hospital	P4	BB (66)
Elranatamab Plasma Cell Myeloma	Anne Louise Tølbøll Sørensen	P4	BB (66)
Ivonescimab Hepatocellular Carcinoma	Akeso	P4	BB (66)
Nivolumab Kidney Cancer	Guliz Ozgun	P4	BB (66)
Pembrolizumab Head And Neck Squamous Cell Carcinoma	UNC Lineberger Comprehensive Cancer Center	P4	BB (66)
Relatlimab Metastatic Melanoma	Bristol-Myers Squibb	P4	BB (66)
Talquetamab Plasma Cell Myeloma	Anne Louise Tølbøll Sørensen	P4	BB (66)

Showing 226 to 250 of 6,371 assets

PreviousPage 10 of 255Next